Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin...

by Anton Hagenbeek, Hans Mooij, Josée Zijlstra, Pieternella Lugtenburg, Gustaaf van Imhoff, Marcel Nijland, Sanne Tonino, Martin Hutchings, Marjolein Spiering, Roberto Liu, Harm van Tinteren, Marie José Kersten
Published 2019-04-01

Radiologic versus Segmentation Measurements to Quantify Wilms Tumor Volume on MRI in Pediatric Patients

by Myrthe A. D. Buser, Alida F. W. van der Steeg, Marc H. W. A. Wijnen, Matthijs Fitski, Harm van Tinteren, Marry M. van den Heuvel-Eibrink, Annemieke S. Littooij, Bas H. M. van der Velden
Published 2023-04-01

Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature

by Alissa Groenendijk, Filippo Spreafico, Ronald R. de Krijger, Jarno Drost, Jesper Brok, Daniela Perotti, Harm van Tinteren, Rajkumar Venkatramani, Jan Godziński, Christian Rübe, James I. Geller, Norbert Graf, Marry M. van den Heuvel-Eibrink, Annelies M. C. Mavinkurve-Groothuis
Published 2021-06-01

Impact of the COVID‐19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group study

by Prakriti Roy, Sophie E. vanPeer, Rana Dandis, Catriona Duncan, Joaquim Caetano deAguirre‐Neto, Arnauld Verschuur, Beatriz deCamargo, Henrike E. Karim‐Kos, Luna Boschetti, Filippo Spreafico, Gema L. Ramirez‐Villar, Norbert Graf, Harm vanTinteren, Kathy Pritchard‐Jones, Marry M. van denHeuvel‐Eibrink
Published 2023-08-01

Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 Protocol

by Raquel Dávila Fajardo, Rhoikos Furtwängler, Martine van Grotel, Harm van Tinteren, Claudia Pasqualini, Kathy Pritchard-Jones, Reem Al-Saadi, Beatriz de Camargo, Gema L. Ramírez Villar, Norbert Graf, Xavier Muracciole, Patrick Melchior, Daniel Saunders, Christian Rübe, Marry M. van den Heuvel-Eibrink, Geert O. Janssens, Arnauld C. Verschuur
Published 2021-02-01

International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study

by Joaquim Caetano de Aguirre-Neto, Beatriz de Camargo, Harm van Tinteren, Christophe Bergeron, Jesper Brok, Gema Ramírez-Villar, Arnauld Verschuur, Rhoikos Furtwängler, Lisa Howell, Daniel Saunders, Oystein Olsen, Aurore Coulomb, Christian Vokuhl, Jan Godzinski, Anne M. Smets, Gordan M. Vujanic, Marry M. van den Heuvel-Eibrink, Norbert Graf, Kathy Pritchard-Jones
Published 2022-05-01

The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia

by Valeria Ceolin, Sae Ishimaru, Seth E. Karol, Francisco Bautista, Bianca Frederika Goemans, Gwenaëlle Gueguen, Marieke Willemse, Laura Di Laurenzio, Jennifer Lukin, Harm van Tinteren, Franco Locatelli, Arnaud Petit, Daisuke Tomizawa, Alice Norton, Gertjan Kaspers, Dirk Reinhardt, Sarah K. Tasian, Gwen Nichols, Edward Anders Kolb, Christian Michel Zwaan, Todd Michael Cooper
Published 2023-12-01

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transp...

by Marie José Kersten, Julia Driessen, Josée M. Zijlstra, Wouter J. Plattel, Franck Morschhauser, Pieternella J. Lugtenburg, Pauline Brice, Martin Hutchings, Thomas Gastinne, Roberto Liu, Coreline N. Burggraaff, Marcel Nijland, Sanne H. Tonino, Anne I.J. Arens, Roelf Valkema, Harm van Tinteren, Marta Lopez-Yurda, Arjan Diepstra, Daphne De Jong, Anton Hagenbeek
Published 2020-04-01

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

by Thomas F. Eleveld, Thomas F. Eleveld, Lindy Vernooij, Linda Schild, Bianca Koopmans, Lindy K. Alles, Marli E. Ebus, Rana Dandis, Harm van Tinteren, Huib N. Caron, Jan Koster, Max M. van Noesel, Godelieve A. M. Tytgat, Selma Eising, Rogier Versteeg, M. Emmy M. Dolman, M. Emmy M. Dolman, M. Emmy M. Dolman, Jan J. Molenaar, Jan J. Molenaar
Published 2023-02-01

Patterns of Hearing Loss in Irradiated Survivors of Head and Neck Rhabdomyosarcoma

by Franciscus A. Diepstraten, Jan Wiersma, Reineke A. Schoot, Rutger R. G. Knops, Charlotte L. Zuur, Annelot J. M. Meijer, Raquel Dávila Fajardo, Bradley R. Pieters, Brian V. Balgobind, Henrike Westerveld, Nicole Freling, Harm van Tinteren, Ludwig E. Smeele, Arjan Bel, Marry M. van den Heuvel-Eibrink, Robert J. Stokroos, Johannes H. M. Merks, Alexander E. Hoetink, Marinka L. F. Hol
Published 2022-11-01

Bilateral Renal Tumors in Children: The First 5 Years’ Experience of National Centralization in The Netherlands and a Narrative Review of the Literature

by Sophie E. van Peer, Janna A. Hol, Alida F. W. van der Steeg, Martine van Grotel, Godelieve A. M. Tytgat, Annelies M. C. Mavinkurve-Groothuis, Geert O. R. Janssens, Annemieke S. Littooij, Ronald R. de Krijger, Marjolijn C. J. Jongmans, Marc R. Lilien, Jarno Drost, Roland P. Kuiper, Harm van Tinteren, Marc H. W. A. Wijnen, Marry M. van den Heuvel-Eibrink
Published 2021-11-01

Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line Therapy

by Anouk Steur, Paulien A. M. A. Raymakers-Janssen, Martin C. J. Kneyber, Sandra Dijkstra, Job B. M. van Woensel, Dick A. van Waardenburg, Cornelis P. van de Ven, Alida F. W. van der Steeg, Marc Wijnen, Marc R. Lilien, Ronald R. de Krijger, Harm van Tinteren, Annemieke S. Littooij, Geert O. Janssens, Annemarie M. L. Peek, Godelieve A. M. Tytgat, Annelies M. Mavinkurve-Groothuis, Martine van Grotel, Marry M. van den Heuvel-Eibrink, Roelie M. Wösten-van Asperen
Published 2022-02-01

Characteristics and outcome of children with renal tumors in the Netherlands: The first five-year's experience of national centralization.

by Prakriti Roy, Sophie E van Peer, Martin M de Witte, Godelieve A M Tytgat, Henrike E Karim-Kos, Martine van Grotel, Cees P van de Ven, Annelies M C Mavinkurve-Groothuis, Johannes H M Merks, Roland P Kuiper, Janna A Hol, Geert O R Janssens, Ronald R de Krijger, Marjolijn C J Jongmans, Jarno Drost, Alida F W van der Steeg, Annemieke S Littooij, Marc H W A Wijnen, Harm van Tinteren, Marry M van den Heuvel-Eibrink
Published 2022-01-01

P676: UPDATED RESULTS FROM THE TRIAL ITCC-054/COG-AAML1921: BOSUTINIB IN NEWLY DIAGNOSED AND RESISTANT/INTOLERANT PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA

by Erica Brivio, Edoardo Pennesi, Marieke Willemse, Yilin Jiang, Vincent van der Velden, Berna Beverloo, Chad Hudson, Luke Kuttschreuter, Inge van der Sluis, Benoît Brethon, Francisco Bautista, Michael J. Burke, Nyla Heerema, Andrew Bukowinski, Stacy Cooper, Jessica Pollard, Ramamoorthy Nagasubramani, Michele Redell, Jean-Pierre Bourquin, Ray Pais, Jamie Frediani, Sandeep Batra, Nicoletta Bertorello, Jessica Boklan, Albert Kheradpour, Wade Kyono, Karey Kowalski, Benjamin Mizukawa, Donna Lancaster, Laura Murillo-Sanjuán, Julie Krystal, Yves Bertrand, Alwin Huitema, Harm van Tinteren, Franco Locatelli, Michael Roth, Nobuko Hijiya, Michel Zwaan
Published 2023-08-01